Last reviewed · How we verify
S.L.®
At a glance
| Generic name | S.L.® |
|---|---|
| Also known as | Andolex® |
| Sponsor | Chang Gung Memorial Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Effects of Two Oral Bioactive Collagen Peptides On Skin Properties and Aging Hallmarks (NA)
- DMAE Oleate for Facial Skin Firmness and Fine Lines in Healthy Adults (NA)
- Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement (NA)
- Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women (NA)
- Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea. (NA)
- Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral (NA)
- Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route (PHASE1)
- Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- S.L.® CI brief — competitive landscape report
- S.L.® updates RSS · CI watch RSS
- Chang Gung Memorial Hospital portfolio CI